Richard Silver to Lung Diseases, Interstitial
This is a "connection" page, showing publications Richard Silver has written about Lung Diseases, Interstitial.
Connection Strength
6.426
-
Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis. Arthritis Rheumatol. 2023 03; 75(3):438-448.
Score: 0.754
-
Systemic sclerosis: Choosing patients wisely when treating interstitial lung disease. Nat Rev Rheumatol. 2017 08; 13(8):455-456.
Score: 0.513
-
Management of Systemic-Sclerosis-Associated Interstitial Lung Disease. Rheum Dis Clin North Am. 2015 Aug; 41(3):439-57.
Score: 0.443
-
Update on scleroderma-associated interstitial lung disease. Curr Opin Rheumatol. 2014 Nov; 26(6):630-6.
Score: 0.426
-
Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis. J Comput Assist Tomogr. 2014 Mar-Apr; 38(2):163-8.
Score: 0.407
-
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum. 2011 May; 63(5):1416-25.
Score: 0.334
-
Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence. Semin Arthritis Rheum. 2010 Dec; 40(3):241-9.
Score: 0.313
-
Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum. 2010 Aug; 40(1):73-88.
Score: 0.285
-
Endothelin and scleroderma lung disease. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v25-6.
Score: 0.280
-
Histopathology and bronchoalveolar lavage. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v62-4.
Score: 0.280
-
New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol. 2005 Nov; 17(6):737-45.
Score: 0.228
-
Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020 03; 8(3):304-320.
Score: 0.154
-
Assessment and management of scleroderma lung disease. Curr Opin Rheumatol. 1999 Nov; 11(6):508-13.
Score: 0.151
-
Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067.
Score: 0.151
-
Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):115-124.
Score: 0.149
-
Voriconazole-associated periostitis presenting as hypertrophic osteoarthropathy following lung transplantation report of two cases and review of the literature. Semin Arthritis Rheum. 2019 10; 49(2):319-323.
Score: 0.145
-
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.
Score: 0.142
-
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
Score: 0.120
-
Interstitial lung disease of systemic sclerosis. Int Rev Immunol. 1995; 12(2-4):281-91.
Score: 0.108
-
Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease. Arthritis Rheumatol. 2014 Jul; 66(7):1909-19.
Score: 0.104
-
Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease. Curr Rheumatol Rep. 2014 Apr; 16(4):411.
Score: 0.102
-
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2014 Apr 15; 306(8):L736-48.
Score: 0.102
-
Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
Score: 0.100
-
Coagulation and autoimmunity in scleroderma interstitial lung disease. Semin Arthritis Rheum. 2011 Oct; 41(2):212-22.
Score: 0.081
-
Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol. 2010 Mar-Apr; 28(2 Suppl 58):S55-62.
Score: 0.079
-
Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009 Apr; 36(4):773-80.
Score: 0.072
-
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009 Feb; 36(2):330-6.
Score: 0.071
-
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol. 2008 May; 294(5):L843-61.
Score: 0.067
-
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8.
Score: 0.065
-
Interstitial lung disease in systemic sclerosis. Lung. 2007 Jul-Aug; 185(4):211-20.
Score: 0.064
-
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66.
Score: 0.060
-
Scleroderma. Clinical problems. The lungs. Rheum Dis Clin North Am. 1996 Nov; 22(4):825-40.
Score: 0.031
-
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013 Nov; 72(11):1747-55.
Score: 0.025
-
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis. 2009 May; 68(5):620-8.
Score: 0.018